Currently, there are 8.25M common shares owned by the public and among those 5.35M shares have been available to trade.
The company’s stock has a 5-day price change of 307.66% and 364.10% over the past three months. CRVO shares are trading 286.75% year to date (YTD), with the 12-month market performance down to -46.73% lower. It has a 12-month low price of $1.80 and touched a high of $26.38 over the same period. CRVO has an average intraday trading volume of 3.98 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 187.35%, 249.37%, and -16.52% respectively.
Institutional ownership of CervoMed Inc (NASDAQ: CRVO) shares accounts for 18.00% of the company’s 8.25M shares outstanding.
It has a market capitalization of $74.69M and a beta (3y monthly) value of 0.88. The earnings-per-share (ttm) stands at -$1.64. Price movements for the stock have been influenced by the stock’s volatility, which stands at 62.97% over the week and 20.23% over the month.
Earnings per share for the fiscal year are expected to increase by 23.06%, and -21.17% over the next financial year. EPS should shrink at an annualized rate of 3.71% over the next five years, compared to 73.43% over the past 5-year period.
Looking at the support for the CRVO, a number of firms have released research notes about the stock. Chardan Capital Markets stated their Buy rating for the stock in a research note on March 13, 2025, with the firm’s price target at $14. D. Boral Capital on their part issued Hold rating on December 10, 2024.
